Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Valantine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
St. George's Hospital Medical SchoolClass of 1978
Certifications & Licensure
CA State Medical License 1988 - 2026
Clinical Trials
- IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Start of enrollment: 2005 Jan 01
- Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation Start of enrollment: 2010 Jul 01
- Heartsbreath Test for Heart Transplant Rejection Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Advocating for collaboration among key partners to promote diversity in clinical studies amid policy challenges in the United States of America.Samuel Byiringiro, Juliana K Garcia, Nsenga Farrell, Bunmi Ogungbe, Rifath Ara Alam Barsha
Trials. 2025-04-02 - Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action.Shannon M Dunlay, Sean P Pinney, Anuradha Lala, Garrick C Stewart, Colleen McIlvennan
JAMA Cardiology. 2025-02-05 - 1 citationsProteomics in Acute Heart Transplant Rejection, On Behalf of the GRAfT Investigators.Jason F Goldberg, Christopher R deFilippi, Christopher Lockhart, Erick R McNair, Shashank S Sinha
Transplantation. 2024-12-03
Journal Articles
- Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart TransplantationKiran Khush, Alan C Yeung, Hannah Valantine, William F Fearon, Journal of Cardiac Failure
Other
- Induction and maintenance of immunosuppressive therapy in cardiac transplantationValantine HA, Pham MX
http://www.uptodate.com/contents/induction-and-maintenance-of-immunosuppressive-therapy-in-cardiac-t
UpToDate, Wolters Kluwer Health - 2012-04-06
Authored Content
- Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart TransplantationDecember 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Join now to see all
Press Mentions
Stanford Researchers Testing Ways to Improve Clinical Trial DiversityJune 22nd, 2022- CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement AwardApril 28th, 2022
- ISHLT Honors Hannah Valantine for Lifetime Achievement in Treating Advanced Heart DiseaseApril 28th, 2022
- Join now to see all
Grant Support
- Eradicating Stereotype Threat: Intervening To Retain And Advance Women FacultyNational Institute Of General Medical Sciences2010
- Genome Transplant Dynamics: Non-Invasive Sequencing-Based Diagnosis Of RejectionNational Institute Of Allergy And Infectious Diseases2010
- Transplant Arteriosclerosis: Viral And Host MechanismsNational Center For Research Resources2004–2007
- Host-Viral Immune Responses--Transplant ArteriosclerosisNational Institute Of Allergy And Infectious Diseases2001–2002
- Core--Clinical Research FacilityNational Institute Of Allergy And Infectious Diseases2001–2002
- Optimization Of Rodent Models Of Transplant CADNational Heart, Lung, And Blood Institute1999
- Immune Mediators Of Acute Cardiac Allograft DysfunctionNational Heart, Lung, And Blood Institute1991–1995
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
